CAROLYN KING: Open Payments
NPI 1477785392 · BLUEFIELD, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$746 in 42 payments from 7 companies in 2025. Trend: 2023 $54 · 2024 $120 · 2025 $746
Food & beverage: $746
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 10 | $190 |
| ABBVIE INC. | 11 | $161 |
| Teva Pharmaceuticals USA, Inc. | 7 | $111 |
| Janssen Pharmaceuticals, Inc | 3 | $101 |
| Vanda Pharmaceuticals Inc. | 5 | $84 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $61 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
Products named: COBENFY, VRAYLAR, AUSTEDO XR, FANAPT, SPRAVATO, TRINTELLIX, REXULTI, INVEGA SUSTENNA.
Industry payments across VA — which companies pay providers there.
